UnitedHealth Group Incorporated

UnitedHealth Group Incorporated

412.02
USD
+4.56
(+1.12%)
18.38EPS
20.87P/E
328.90BMarket Cap
Jan 20Next Earn

Total Valuation

USD

As of September 30, 2026, UnitedHealth Group Incorporated carries a market capitalization of 328.90B, placing it among publicly traded companies globally. Its enterprise value stands at 382.13B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap328.90B
Enterprise Value382.13B

Important Dates

UnitedHealth Group Incorporated's next confirmed earnings release is scheduled for January 20, 2027.

Earnings Date1/20/2027

Share Statistics

As of September 30, 2026, UnitedHealth Group Incorporated has 896.00M shares outstanding.

Shares Outstanding896.00M

Valuation Ratios

As of September 30, 2026, UnitedHealth Group Incorporated trades at a trailing price-to-earnings ratio of 20.87. The price-to-sales ratio is 0.74, and the price-to-book ratio stands at 3.35.

PE Ratio20.87
PS Ratio0.74
PB Ratio3.35
P/TBV Ratio-9.33
P/FCF Ratio14.59
P/OCF Ratio12.66

Enterprise Valuation

As of September 30, 2026, UnitedHealth Group Incorporated trades at an EV/EBITDA multiple of 13.56 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.85 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 15.97 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. UnitedHealth Group Incorporated trades at an EV/FCF ratio of 14.65, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 382.13B versus a market cap of 328.90B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.85
EV / EBITDA13.56
EV / EBIT15.97
EV / FCF14.65

Financial Position

As of September 30, 2026, UnitedHealth Group Incorporated maintains a current ratio of 0.74, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 70.43, indicating elevated leverage, while an interest coverage ratio of 7.31 demonstrates adequate ability to service its debt obligations.

Current Ratio0.74
Quick Ratio0.66
Debt / Equity70.43
Debt / EBITDA2.64
Interest Coverage7.31

Financial Efficiency

USD

Over the twelve months ended September 30, 2026, UnitedHealth Group Incorporated posted a return on equity (ROE) of 16.39, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 11.05 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 5.06, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.03, useful for judging operating efficiency across full business cycles. The company generates approximately 1.15M in revenue per employee across its workforce of 390,000.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)16.39
Return on Assets (ROA)5.06
Return on Invested Capital (ROIC)11.05
Return on Capital Employed (ROCE)10.03
Revenue Per Employee1.15M
Employee Count390,000.00

Taxes

USD

Over the twelve months ended September 30, 2026, UnitedHealth Group Incorporated recorded 3.07B in income tax expense. That works out to an effective tax rate of 15.54, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 19.74B, leaving 15.88B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax3.07B
Effective Tax Rate15.54

Stock Price Statistics

USD

As of the close on November 16, 2026, UnitedHealth Group Incorporated's stock has gained approximately 28.01% over the past 52 weeks. The 50-day moving average sits at 391.73, while the 200-day moving average is 367.06.

52-Week Price Change28.01%
50-Day Moving Average391.73
200-Day Moving Average367.06

Income Statement

USD

Over the twelve months ended September 30, 2026, UnitedHealth Group Incorporated generated 449.66B in revenue and converted that into 15.88B in net income, yielding earnings per share of 18.38. EBITDA reached 28.18B, while operating income came in at 23.92B.

Revenue449.66B
Gross Profit89.21B
Operating Income23.92B
Pretax Income19.74B
Net Income15.88B
EBITDA28.18B
EBIT23.92B
Earnings Per Share (EPS)18.38

Balance Sheet

USD

As of September 30, 2026, UnitedHealth Group Incorporated holds 28.55B in cash and equivalents against 74.33B in total debt, resulting in a net debt position of 48.49B. Total book value stands at 98.10B, with working capital of -30.24B providing operational flexibility.

Cash & Cash Equivalents28.55B
Total Debt74.33B
Net Debt48.49B
Equity (Book Value)98.10B
Book Value Per Share109.48
Working Capital-30.24B

Cash Flow

USD

UnitedHealth Group Incorporated produced 26.20B in operating cash flow over the twelve months ended September 30, 2026. After subtracting -3.37B in capital expenditures, free cash flow totaled 22.83B - equivalent to 25.27 per share.

Operating Cash Flow26.20B
Capital Expenditures-3.37B
Free Cash Flow22.83B
FCF Per Share25.27

Margins

Over the twelve months ended September 30, 2026, UnitedHealth Group Incorporated posted a gross margin of 19.84, reflecting its pricing power and cost economics. The operating margin of 5.32 and net profit margin of 3.53 provide insight into operational efficiency.

Gross Margin19.84
Operating Margin5.32
Pretax Margin4.39
Profit Margin3.53
EBITDA Margin6.27

Dividends & Yields

USD

Over the twelve months ended September 30, 2026, UnitedHealth Group Incorporated paid dividends of 9.05 per share. The dividend payout ratio of 46.82 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 6.86, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 4.88, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to UnitedHealth Group Incorporated shareholders.

Dividend Per Share9.05
Payout Ratio46.82
Shareholder Yield4.88
FCF Yield6.86

Stock Splits

UnitedHealth Group Incorporated's most recent stock split took place on May 31, 2005 with a 1:2 split ratio.

Last Split Date5/31/2005
Split Ratio1:2

Scores

As of September 30, 2026, UnitedHealth Group Incorporated has an Altman Z-Score of 4.49, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.49